Dr. Hwang on First-line Treatment Options in HCCByJimmy Hwang, MDMarch 13th 2023Jimmy Hwang, MD, discusses currently available first-line treatment options in hepatocellular carcinoma, and areas of continued unmet need in this space.
Dr. Hwang on Considerations for Second-Line Treatment in Gastric/GEJ CancerByJimmy Hwang, MDJuly 1st 2021Jimmy Hwang, MD, discusses considerations for second-line treatment in gastric/gastroesophageal junction cancer.